HydroxyureaRibonucleotide Reductase InhibitorCat.No.S189650 mg and 1 more item
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0447088-V3
- Awardee
- Selleck Chem LLC
- Contracting organization
- University of Virginia
- Cumulative value
- $317.00
About this award
Selleck Chem LLC was awarded a contract by the University of Virginia on August 8, 2026, valued at $317. The contract, identified as A207_PO-0447088-V3, involves the procurement of pharmaceutical research materials in Virginia. The award encompasses two distinct chemical compounds: Rabusertib (LY2603618), a Chk1 inhibitor (catalog number S26265), and Hydroxyurea, a ribonucleotide reductase inhibitor (catalog number S1896).
Under this purchase order, Selleck Chem LLC will deliver 170 units of Rabusertib and 147 units of Hydroxyurea to the University of Virginia buyer. Each unit is priced at $1, resulting in the cumulative contract value of $317. No specific period of performance or place of performance beyond the University of Virginia is documented in the contract award materials provided.
Line items
| Item | Total |
|---|---|
| Rabusertib (LY2603618)Chk1 inhibitorCat.No.S26265mg | $170.00 |
| HydroxyureaRibonucleotide Reductase InhibitorCat.No.S189650 mg | $147.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0447088-V3?
Contract A207_PO-0447088-V3 was awarded to Selleck Chem LLC by University of Virginia on August 8, 2026.
How much is contract A207_PO-0447088-V3 worth?
Its cumulative value is $317.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award